Connection
Benjamin Frank to Phosphodiesterase 5 Inhibitors
This is a "connection" page, showing publications Benjamin Frank has written about Phosphodiesterase 5 Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.050 |
|
|
|
-
Issapour A, Frank B, Crook S, Hite MD, Dorn ML, Rosenzweig EB, Ivy DD, Krishnan US. Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience. Pediatr Pulmonol. 2022 03; 57(3):724-733.
Score: 0.050